Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila

Huntington's disease (HD) is a genetic neurodegenerative disease characterized by movement disorders, cognitive decline and neuropsychiatric symptoms. HD is caused by expanded CAG tract within the coding region of Huntingtin protein. Despite major insights into the molecular mechanisms leading to HD, no effective cure is yet available. Mutant Huntingtin (mHtt) has been reported to alter the stability and levels of β-Catenin, a key molecule in cell adhesion and signal transduction in Wingless (Wg)/Wnt pathway. However it remains to establish whether manipulation of Wg/Wnt signaling can impact HD pathology. We here investigated the phenotypic interactions between mHtt and Wg/Wnt signaling by using the power of Drosophila genetics. We provide compelling evidence that reducing Armadillo/β-Catenin levels confers protection and that this beneficial effect is correlated with the inactivation of the canonical Wg/Wnt signaling pathway. Knockdowns of Wnt ligands or of the downstream transcription factor Pangolin/TCF both ameliorate the survival of HD flies. Similarly, overexpression of one Armadillo/β-Catenin destruction complex component (Axin, APC2 or Shaggy/GSK-3β) increases the lifespan of HD flies. Loss of functional Armadillo/β-Catenin not only abolishes neuronal intrinsic but also glia-induced alterations in HD flies. Our findings highlight that restoring canonical Wg/Wnt signaling may be of therapeutic value.

[1]  B. Wang,et al.  Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus , 2002, Nature.

[2]  S. Birman,et al.  AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease. , 2007, Human molecular genetics.

[3]  M. MacDonald,et al.  Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells* , 2003, Journal of Biological Chemistry.

[4]  G. Mcallister,et al.  Evidence for an enhancement of excitatory transmission in adult CNS by Wnt signaling pathway modulation , 2007, Molecular and Cellular Neuroscience.

[5]  A. Bejsovec Flying at the head of the pack: Wnt biology in Drosophila , 2006, Oncogene.

[6]  L. Raymond,et al.  Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.

[7]  Carlos Cepeda,et al.  Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF , 2004, Journal of neuroscience research.

[8]  Shao-Jun Tang,et al.  Activity-dependent Synaptic Wnt Release Regulates Hippocampal Long Term Potentiation* , 2006, Journal of Biological Chemistry.

[9]  Carlos Cepeda,et al.  Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease , 2009, The Journal of Neuroscience.

[10]  M. Peifer,et al.  Roles of Armadillo, a Drosophila catenin, during central nervous system development , 1998, Current Biology.

[11]  M. Bourouis Targeted increase in shaggy activity levels blocks wingless signaling , 2002, Genesis.

[12]  A. Abhyankar,et al.  β-Catenin is involved in alterations in mitochondrial activity in non-transformed intestinal epithelial and colon cancer cells , 2009, British Journal of Cancer.

[13]  M. Hayden,et al.  Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. , 2008, Human molecular genetics.

[14]  Carlos Cepeda,et al.  Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease , 2009, The Journal of Neuroscience.

[15]  N. Fredj,et al.  Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release , 2006, The Journal of cell biology.

[16]  N. Inestrosa,et al.  Wnt-5a Modulates Recycling of Functional GABAA Receptors on Hippocampal Neurons , 2010, The Journal of Neuroscience.

[17]  Rebecca L. Webb,et al.  Testing hypotheses for the functions of APC family proteins using null and truncation alleles in Drosophila , 2006, Development.

[18]  S. Humbert,et al.  Mutant huntingtin‐impaired degradation of β‐catenin causes neurotoxicity in Huntington's disease , 2010, The EMBO journal.

[19]  L. Espinosa,et al.  Phosphorylation by Glycogen Synthase Kinase-3β Down-regulates Notch Activity, a Link for Notch and Wnt Pathways* , 2003, Journal of Biological Chemistry.

[20]  V. Pantesco,et al.  Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch , 1993, Nature.

[21]  M. Tanouye,et al.  Modifications of seizure susceptibility in Drosophila. , 2000, Journal of neurophysiology.

[22]  J. Olson,et al.  Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration , 2007, PLoS genetics.

[23]  R. Nusse,et al.  A Drosophila Axin homolog, Daxin, inhibits Wnt signaling. , 1999, Development.

[24]  F. Barrantes,et al.  Wnt-7a Induces Presynaptic Colocalization of α7-Nicotinic Acetylcholine Receptors and Adenomatous Polyposis Coli in Hippocampal Neurons , 2007, The Journal of Neuroscience.

[25]  Chuan-en Wang,et al.  Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.

[26]  R. Moon,et al.  Canonical Wnt3a Modulates Intracellular Calcium and Enhances Excitatory Neurotransmission in Hippocampal Neurons* , 2010, The Journal of Biological Chemistry.

[27]  N. Inestrosa,et al.  Wnt-7a Modulates the Synaptic Vesicle Cycle and Synaptic Transmission in Hippocampal Neurons* , 2008, Journal of Biological Chemistry.

[28]  L. Juliano,et al.  Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling* , 2008, Journal of Biological Chemistry.

[29]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[30]  Barry Ganetzky,et al.  Metabolic Disruption in Drosophila Bang-Sensitive Seizure Mutants , 2006, Genetics.

[31]  J. Ávila,et al.  Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. , 2002, Bipolar disorders.

[32]  M. Beal,et al.  Oxidative damage in Huntington's disease pathogenesis. , 2006, Antioxidants & redox signaling.

[33]  R. Xavier,et al.  Wnt signaling regulates mitochondrial physiology and insulin sensitivity. , 2010, Genes & development.

[34]  Linda Partridge,et al.  Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease , 2010, PLoS genetics.

[35]  D. Geschwind,et al.  Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.

[36]  Enrique M. Toledo,et al.  Wnt signaling in neuroprotection and stem cell differentiation , 2008, Progress in Neurobiology.

[37]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[38]  F. Walker Huntington's disease , 2007, The Lancet.

[39]  K. Broadie,et al.  Cellular bases of activity-dependent paralysis in Drosophila stress-sensitive mutants. , 2004, Journal of neurobiology.

[40]  D. Rubinsztein,et al.  Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation* , 2002, The Journal of Biological Chemistry.

[41]  Carlos Cepeda,et al.  Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease , 2003, The Journal of Neuroscience.

[42]  Stephan J. Sigrist,et al.  Rapid Activity-Dependent Modifications in Synaptic Structure and Function Require Bidirectional Wnt Signaling , 2008, Neuron.

[43]  N. Inestrosa,et al.  Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils , 2003, Molecular Psychiatry.